clofibrate has been researched along with Lupus Erythematosus, Systemic in 2 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, EJ | 1 |
| Brown, SM | 1 |
2 other studies available for clofibrate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
When a drug is the culprit.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clofibrate; Depression; Drug-Related Side Effect | 1973 |
Letter: Clofibrate-induced antinuclear factor and lupus-like syndrome.
Topics: Aged; Antibodies, Antinuclear; Cholesterol; Clofibrate; Female; Humans; Lupus Erythematosus, Systemi | 1973 |